Most everyone
will be out enjoying the sun during the next several months, and patients
taking medication should beware of photosensitivity. Photosensitivity is a
seasonal occurrence, and there are two varieties of this reaction, including
phototoxicity and photoallergy.
Phototoxic
reaction is exposure to sunlight that may cause medication to absorb
ultraviolet light that releases into the skin. This reaction is related to the
concentration of a drug and will subside when the medication is stopped.
Erythema is present within 24 hours of exposure in a photodistributed
dermatitis. Edema, vesicles and bullae may also occur, but are uncommon.
Common
medications that cause phototoxicity include amiodarone, fluoroquinolones, furosemide,
sulfonamides, sulfonylurea, tetracyclines and thiazides. This is not an exhaustive
list.
Photoallergic
reaction is not drug concentration dependent. Eruption does not occur until 48
hours after exposure and will appear in areas that are not exposed to UV light.
Physical appearance is varied compared to phototoxicity. Patients with
photoallergy present with an intensely pruritic eczematous dermatitis that can
progress to lichenification. A portion of patients can develop a persistent
exquisite hypersensitivity reaction after the offending medication has been
discontinued, called persistent light reaction, which can occur in up to 10
percent of patients with photoallergy.
Photoallergic
medications include chlorpromazine, fluoroquinolones, piroxicam, promethazine
and sulfa containing medications.
Diagnosis
of photosensitivity can generally be confirmed with a thorough history and
review of medications. Diagnostic
methods include photopatch testing to determine photoallergy. Photopatch is
similar to allergy patch testing, using patches that contain known
photoallergens that are applied to the patient. Development of eczematous
patches is a positive result. Testing for phototoxicity includes Minimal
Erythema Dose evaluation.
The first
line of photosensitivity treatment is discontinuing the medication. Minimizing
sun exposure is also of importance even after reaction has occurred. Acute
symptoms of phototoxicity can be alleviated with cool compresses, topical
steroids and oral NSAIDs. If a patient is severely affected, a steroid taper is
beneficial. Photoallergic reactions can be managed similarly.
There
are very few patients that suffer from persistent light reaction and chronic
actinic dermatitis. Management for these patients includes vigilant protection
against UV light exposure. Cytotoxic agents are a treatment option if other
methods have failed.
Common
sense is always a good start. Remind people to wear sunscreen, read medication warning
labels and call their doctor if they have any questions.
Dr. Colleen Donohue is a board-certified primary care physician with Brookwood Medical
Center.
No comments:
Post a Comment